Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

dc.contributor.author	Casal Rubio, Joaquín
dc.date.accessioned	2017-06-07T07:24:58Z
dc.date.available	2017-06-07T07:24:58Z
dc.date.issued	2015
dc.identifier.issn	1699-048
dc.identifier.uri	http://hdl.handle.net/20.500.11940/6172
dc.language.iso	eng
dc.title	Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
dc.type	Artigo	es
dc.authorsophos	Salvador, J
dc.authorsophos	Manso, L
dc.authorsophos	Haba, J. de la
dc.authorsophos	Jaen, A
dc.authorsophos	Ciruelos, E
dc.authorsophos	Villena, M. C. de
dc.authorsophos	Gil, M
dc.authorsophos	Murias, A
dc.authorsophos	Galan, A
dc.authorsophos	Jara, C
dc.authorsophos	Bayo, J
dc.authorsophos	Baena, J. M
dc.authorsophos	Casal, J
dc.authorsophos	Mel, J. R
dc.authorsophos	Blancas, I
dc.authorsophos	Sanchez Rvira, P.
dc.identifier.doi	10.1007/s12094-014-1210-x.
dc.identifier.isi	349307800010
dc.identifier.pmid	25119930
dc.identifier.sophos	19950
dc.issue.number	2
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Oncoloxía médica
dc.page.final	326
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	17

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.